Skip to main content

WCG Unveils 2025 Trends and Insights Report: Driving Innovation and Excellence in Clinical Research

Princeton, NJ – January 7, 2025 – WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the release of its 2025 Trends and Insights Report. This annual report offers a deep dive into the critical trends shaping clinical trials that deliver lifesaving therapies to patients worldwide. 

Leveraging WCG’s extensive expertise, the report identifies five pivotal focus areas for 2025: 

  1. AI and Machine Learning – Enhancing operational efficiency by revolutionizing trial design, participant recruitment, and site performance. 
  1. Site Preparedness for Future Clinical Trials – Elevating infrastructure, training, and collaboration to drive site success and participant engagement. 
  1. Regulatory Innovation and Single IRB Models – Streamlining review processes to reduce redundancy and accelerate multi-site study start-up times. 
  1. Precision Oncology and Biomarker-Driven Trials – Delivering a new gold standard in personalized medicine with targeted, biomarker-based approaches. 
  1. Diversity in Clinical Trials – Breaking barriers to representation through innovative recruitment models and community engagement strategies, ensuring equitable access to life-changing therapies. 

“The 2025 WCG Trends and Insights Report encapsulates the innovation and personalization that define the future of clinical research,” said Sam Srivastava, chief executive officer of WCG. “At WCG, we are committed to empowering stakeholders across the research ecosystem with actionable insights that improve outcomes, accelerate trials, and ultimately, improve patient care. This year’s report is both a roadmap and a call to action for advancing clinical trials with purpose and precision.” 

With these key themes, the report equips sponsors, CROs, sites, and regulators with the valuable insights needed to effectively navigate an evolving landscape, from the rise of artificial intelligence to the imperative need to foster diversity in clinical trials. Successfully addressing these areas will ultimately lead to better clinical outcomes in our industry, enhancing participant care and ensuring the delivery of more efficient and effective therapies to patients worldwide. 

The 2025 WCG Trends and Insights Report is now available. To access the report, visit wcgclinical.com

About WCG

WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical